Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives (Q77449550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

H Hoffmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Moore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

H Zimmermann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

W Elger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Schwarz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Gräser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Oettel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Toxicologic Pathology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

458-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Oral contraceptive containing natural estradiol for premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Ovulation inhibitors: the significance of estrogen dose

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Comparative pharmacology of newer progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

New knowledge in the physiology of hormonal contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Risks and mechanisms of cardiovascular events in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Natural oestrogens for oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Balanced view of risks of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Estrogen therapy and liver function--metabolic effects of oral and parenteral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2898%2980034-1

7 January 2021

10.1016/S0940-2993(98)80034-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9784023%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference